| View |
|
DRP-7215-01
|
Letrozole
|
None
|
2.5 mg
|
Film-Coated Tablet
|
Antineoplastic (Aromatase inhibitor)
|
Cadila Healthcare Ltd
|
India
|
-
|
07 January 2022
|
11 April 2026
|
| View |
|
DRP-7306-01
|
Valsartan
|
None
|
80 mg
|
Film-Coated Tablet
|
Antihypertensive (Angiotensin II Receptor Blocker)
|
Cadila Healthcare Limited
|
India
|
-
|
07 January 2022
|
08 September 2026
|
| View |
|
DRP-7334-01
|
Salbutamol (as sulfate)
|
None
|
100 mcg Per Actuation Metered Dose Inhaler (CFC-Free)
|
|
Anti-Asthma
|
Cadila Healthcare Limited
|
India
|
-
|
07 January 2022
|
08 July 2026
|
| View |
|
DRP-6015-02
|
Dutasteride
|
Dutapan
|
500 mcg
|
Film-Coated Tablet
|
5 – Alpha Reductase Inhibitor
|
Akums Drugs & Pharmaceuticals Ltd
|
India
|
Renewal
|
07 May 2024
|
20 February 2030
|
| View |
|
DRP-8217-01
|
Oxytetracycline (as hydrochloride) + Polymyxin B Sulfate
|
TETRAPOL
|
5 mg/10,000 IU per gram
|
Ophthalmic Ointment
|
Antibacterial (Tetracyclines)
|
Egyptian International Pharmaceutical Industries Co, (EIPICO)
|
Egypt
|
Renewal
|
16 May 2024
|
07 June 2029
|
| View |
|
DRP-8994-06
|
Gliclazide
|
None
|
60 mg Modified Release Tablet
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
07 January 2022
|
14 August 2025
|
| View |
|
DRP-9094-01
|
Ascorbic acid + Zinc
|
None
|
500 mg/10 mg
|
Capsule
|
Vitamin/Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
07 January 2022
|
25 August 2025
|
| View |
|
DRP-10426-01
|
Febuxostat
|
Fexoxan
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Gracure Pharmaceutical Ltd
|
India
|
-
|
07 January 2022
|
04 November 2026
|
| View |
|
DRP-9299-01
|
Ascorbic Acid + Zinc
|
Amor-Z
|
533.40 mg (equivalent to 600 mg Sodium Ascorbate) / 10
mg (equivalent to 27.45 mg Zinc Sulfate Monohydrate)
Capsule
|
Capsule
|
Vitamin/Mineral
|
Interchemex Laboratories, Inc.
|
Philippines
|
-
|
05 January 2022
|
17 November 2025
|
| View |
|
DR-XY37826
|
Iron (as sucrose)
|
Feron
|
20 mg/mL (100 mg/5 mL) Solution for I.V. Injection
|
Solution for I.V. Injection
|
Antianemic
|
Gland Pharma Limited
|
India
|
-
|
28 February 2022
|
23 April 2027
|
| View |
|
DRP-3710-05
|
Telmisartan
|
Mistacor 80
|
80 mg
|
Tablet
|
Angiotensin II Antagonist
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
28 February 2022
|
29 March 2027
|
| View |
|
DRP-8492
|
Hyoscine-N-Butylbromide
|
Spasmotidine
|
10 mg
|
Tablet
|
Anticholinergic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
17 February 2022
|
27 March 2027
|
| View |
|
DR-XY39930
|
Simethicone
|
Gazgo
|
200mg
|
Capsule
|
Antiflatulent
|
Mega Lifesciences Public Company Limited
|
Thailand
|
Automatic Renewal
|
09 February 2022
|
15 August 2026
|
| View |
|
DRP-455-03
|
Cefuroxime (as Axetil)
|
Truxim
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Flamingo Pharmaceuticals Ltd.
|
India
|
-
|
05 February 2022
|
05 February 2027
|
| View |
|
DRP-7761-02
|
Mefenamic Acid
|
Gisfen
|
500 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Hizon Laboratories, Inc
|
Philippines
|
-
|
28 February 2022
|
31 May 2026
|
| View |
|
DRP-8584-12
|
Pantoprazole (as sodium sesquihydrate) + Domperidone
|
Jiaazole-D
|
40 mg/30 mg
|
Modified Release Capsule
|
Proton Pump Inhibitor/ Gastrokinetic
|
Theon Pharmaceuticals Limited
|
India
|
-
|
28 February 2022
|
18 December 2024
|
| View |
|
DRP-11323
|
Gentamicin (as sulfate)
|
Gentacare
|
80 mg/2 mL (40 mg/mL)
|
Solution for Injection (I.M./I.V.)
|
-
|
Grand Pharmaceutical (China) Co., Ltd
|
China
|
-
|
22 March 2023
|
02 September 2028
|
| View |
|
DRP-4740-01
|
Olmesartan Medoxomil + Hydrochlorothiazide
|
Olmegnan
|
40 mg/ 12.5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
15 March 2023
|
25 September 2028
|
| View |
|
DRP-1182-04
|
Cetirizine Dihydrochloride
|
Dumparin
|
10 mg
|
Tablet
|
H1-Receptor Antagonist (Antihistamine)
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Renewal
|
31 July 2023
|
16 December 2028
|
| View |
|
DRP-10801-02
|
Sodium bicarbonate
|
AcidNorm
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V.
Infusion)
|
Electrolyte Replenisher/Systemic Alkalinising Agent
|
BC World Pharm. Co., Ltd.
|
Korea
|
-
|
23 February 2022
|
21 December 2026
|